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Abstract
Background: Although targeted temperature management (TTM) is recommended in comatose survivors after
cardiac arrest (CA), the optimal method to deliver TTM remains unknown. We performed a meta-analysis to
evaluate the effects of different TTM methods on survival and neurological outcome after adult CA.
Methods: We searched on the MEDLINE/PubMed database until 22 February 2019 for comparative studies that
evaluated at least two different TTM methods in CA patients. Data were extracted independently by two authors.
We used the Newcastle-Ottawa Scale and a modified Cochrane ROB tools for assessing the risk of bias of each
study. The primary outcome was the occurrence of unfavorable neurological outcome (UO); secondary outcomes
included overall mortality.
Results: Our search identified 6886 studies; 22 studies (n = 8027 patients) were included in the final analysis. When
compared to surface cooling, core methods showed a lower probability of UO (OR 0.85 [95% CIs 0.75–0.96]; p =
0.008) but not mortality (OR 0.88 [95% CIs 0.62–1.25]; p = 0.21). No significant heterogeneity was observed among
studies. However, these effects were observed in the analyses of non-RCTs. A significant lower probability of both
UO and mortality were observed when invasive TTM methods were compared to non-invasive TTM methods and
when temperature feedback devices (TFD) were compared to non-TFD methods. These results were significant
particularly in non-RCTs.
Conclusions: Although existing literature is mostly based on retrospective or prospective studies, specific TTM
methods (i.e., core, invasive, and with TFD) were associated with a lower probability of poor neurological outcome
when compared to other methods in adult CA survivors (CRD42019111021).
Keywords: Targeted temperature management, Methods, Endovascular, Surface cooling, Survival, Neurological
outcome, Meta-analysis
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Introduction
Effective neuroprotective strategies are required to prevent
or minimize the development of extended anoxic brain in-
jury after cardiac arrest (CA) after the return of spontan-
eous circulation (ROSC) [1]. The use of targeted
temperature management (TTM) is actually recom-
mended in comatose CA survivors, especially after out-of-
hospital cardiac arrest (OHCA) with an initial shockable
rhythm, although the quality of evidence is moderate to
low [2]. In 2002, two randomized clinical trials (RCTs)
showed that TTM at 33 °C for 12–24 h was associated
with a significantly higher proportion of patients achieving
a favorable neurological outcome when compared to any
temperature control [3–5]; more recently, a large RCT
showed that the target temperature during TTM could be
either 33 °C or 36 °C, with an active temperature control
required for all patients [6].
Current guidelines recognized some important know-
ledge gaps in the use of TTM after CA. In particular, al-
though significant delay to initiate TTM could negate
the positive effects of such intervention, RCTs showed
no benefits from early TTM initiation using cold intra-
venous fluids, either during cardiopulmonary resuscita-
tion (CPR) or immediately after ROSC, when compared
to in-hospital TTM implementation [7, 8]. Also, the op-
timal TTM duration remains unknown; while prolonged
therapy up to 72 h is effective in newborns suffering
from anoxic-hypoxic encephalopathy [9], TTM at 33 °C
for 48 h did not significantly improve long-term neuro-
logical outcome when compared to 24 h duration in
adult OHCA [10]. Importantly, all these studies dealing
with early or prolonged cooling strategies suffered from
significant biases and might have been underpowered.
As such, these aspects of TTM after CA, together with
some other issues, such as the selection of patients (i.e.,
shockable vs. non-shockable patients, in-hospital vs.
OHCA), the rewarming rate, and the control of post-
TTM fever, have not been adequately addressed yet.
Moreover, the most effective method to deliver TTM
and how this could influence the patients’ outcome is a
matter of debate. According to international guidelines,
external or internal cooling devices can be used [2]. Sev-
eral devices are available for clinicians, with different
technical characteristics, possibilities of use (i.e., in-hos-
pital vs. out-of-hospital), velocity to achieve target
temperature, precision (i.e., maintenance of the target
temperature within target ranges), invasiveness, potential
side effects, and costs [11]. Furthermore, basic means
(such as ice packs, cold fluid, fans) seem of less precision
and efficiency than automated method (i.e., automatic
adjustment according to patient temperature) [12]. To
date, no RCTs showed the superiority of a specific de-
vice over another [12, 13]. However, most studies found
that endovascular cooling devices (EC) enabled a more
precise temperature control when compared to others
[14, 15] and some of them also reported a non-signifi-
cant trend towards a better survival rate [16, 17].
The aim of this metanalysis was therefore to investi-
gate whether, in patients resuscitated from cardiac arrest
(i.e., participants) undergoing TTM (i.e., intervention),
neurological outcome and survival (i.e., Outcomes) could
be influenced by the different methods used for TTM
(i.e., comparison).
Methods
We adhered to the Preferred Reporting Items for System-
atic Reviews and Meta-Analysis-Protocols (PRISMA-P)
guidelines [18]. The protocol of this study was registered
with the International Prospective Register of Systematic
Reviews (PROSPERO) on 25 January 2019 and finally
approved on 12 February 2019 (CRD42019111021).
Data sources and search strategies
A systematic literature search was performed up to 30
January 2019 in the MEDLINE/PubMed® database. This
approach may have reduced the number of eligible
citations; however, other reference libraries have a
higher proportion of non-English citations, with prob-
ably smaller cohorts of patients for the TTM setting.
However, as one study was already accepted for publica-
tion at that moment [19], the literature search was
extended up to 22 February 2019.
This search included only original studies published in
English in peer-reviewed journals. The search was per-
formed using the following terms: (“hypothermia” OR
“TTM” OR “cooling” OR “cooling method” OR “targeted
temperature management”) AND (“heart arrest” OR
“cardiac arrest” OR “post-anoxic”). In addition, we also
searched the reference lists of all eligible studies as well
as relevant reviews for additional published and unpub-
lished data, searched by contacting experts, and used a
web search for abstracts, proceedings, and unpublished
studies. More details regarding data collection are pre-
sented in Additional file 1: Table S1. Main research
questions, with reference to participants, interventions,
comparisons, outcomes, and study design (PICOS), are
reported in Additional file 1: Table S1.
Study screening and selection
The studies were independently screened by two au-
thors (LC and CDF), looking at the study titles and
abstracts for potential eligibility. Additional citations
were also identified by the authors of the present re-
view based on their prior knowledge of the literature.
Disagreement between the authors was assessed and
resolved through a third reviewer (WB), who reviewed
the original text of the article. In the analysis, we in-
cluded only the studies that compared at least two
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cooling methods (i.e., one vs. the other) in adult (> 18
years of age) CA patients; studies could be either
retrospective, prospective, or RCTs. Studies conducted
in healthy volunteers or in animal/experimental
models were excluded. Editorials, commentaries, let-
ters to the editor, opinion articles, reviews, meeting
abstracts, case reports, and studies published in other
languages were excluded; all original articles lacking
an abstract and/or quantitative details on neurological
outcome and survival were also excluded. None of
the authors of the original studies was contacted to
obtain further information, as the main outcomes
were all clearly stated in the published manuscript.
From this first pool of selected articles, further criteria
were established for the inclusion in the quantitative
analysis: (a) TTM should be used in both groups (i.e.,
both methods should be used to induce hypothermia at
least at 36 °C or below); (b) when more than one cooling
method was simultaneously used for a group, the group
was classified according to the most frequently used
cooling method used (i.e., if in one group, 90% of pa-
tients receive “method A” and 25% “method B,” the
groups will be considered as being treated with “method
A”); (c) if one of the methods was used only for a limited
time period (i.e., only for the induction of TTM) and
then discontinued, the study was excluded; and (d) if
TTM was attempted using only antipyretics or intraven-
ous drugs (i.e., such as neurotensin, clonidine), the study
was also excluded.
Definitions
Cooling methods were classified as “core” (i.e., EC,
intravenous cold fluids, automated peritoneal lavage,
any dialysis technique, extra-corporeal membrane
oxygenation, esophageal or trans-nasal) or “surface”
(i.e., skin exposure, cooling beds, iced packs, cooling
pads, air-circulating or water-circulating blankets,
water-filled blankets, air-filled blankets) [11]. Add-
itional classifications included “invasive” (i.e., EC, au-
tomated peritoneal lavage, any dialysis technique,
extra-corporeal membrane oxygenation) or “non-inva-
sive” (all the others) and “temperature feedback de-
vices” (TFD, i.e., with a controlled feedback system
that continuously measures the patients’ temperature
and adjust the temperature of the cooling element ac-
cordingly) or “non-TFD.” If a study included multiple
methods, the data were aggregated prior to inclusion
in the systematic review according to the abovemen-
tioned definitions (i.e., EC and esophageal cooling
devices would be considered together as “core,” but
EC will eventually be included in the “invasive” group
while esophageal cooling devices in the “non-invasive”
group).
Appraisal of study quality
The level of evidence (LOE) of each study was assessed
according to the Grading of Recommendations, Assess-
ment, Development and Evaluations (GRADE) evidence
system [20]. The risk of bias for RCTs was assessed
using a modified Cochrane ROB tool that classifies ROB
as “low,” “probably low,” “probably high,” or “high” for
each of the following domains: sequence generation,
allocation sequence concealment, blinding, selective out-
come reporting, and other bias [21]. The risk of bias of
non-RCTs was assessed using the Newcastle-Ottawa
Scale [22]; in particular, we evaluated three components:
(a) selection of cases: studies were considered as “low”
ROB if case definition was adequate, cases were repre-
sentative, and outcome of interest was not present at the
beginning of the study; (b) comparability of cohorts:
studies were considered as “low” ROB if adjustment was
made for usual prognostic factors (i.e., Utstein variables);
(c) exposure and outcome: studies were considered as
“low” ROB if assessment of outcome and follow-up were
appropriate. Overall, a study was considered as “low”
ROB if each single component was classified as “low.”
LOE was further analyzed by two experts (WB, ND) and
one independent statistician. Disagreement was resolved
by consensus.
Primary and secondary outcomes
The primary outcome evaluated was the analysis of
unfavorable neurological outcome, whenever this was
collected and defined as cerebral performance category
of 3–5, in the “core” vs. “surface” group. The secondary
outcome was mortality, whenever this was collected.
Similar subgroup analyses were performed in invasive vs.
non-invasive methods and TFD vs. non-TFD methods.
Pre-defined subgroup analyses were performed in (a) EC
vs. surface, (b) EC vs. surface with TFD, (c) surface blan-
kets vs. other surface methods, as EC and blanket cool-
ing devices, are the most used methods in this setting
worldwide.
Statistical analysis
Means of mortality and poor neurological outcome risks
were obtained by weighting each study by the inverse of
variance. Mantel-Haenszel method was chosen as the
reference method for fixed effects analysis. The Mantel-
Haenszel formula is applied to calculate an overall, un-
confounded, effect estimate of a given exposure for a
specific outcome by combining stratum-specific odds
ratios (OR). Stratum-specific ORs are calculated within
each stratum of the confounding variable and compared
with the corresponding effect estimates in the whole
group. A Z test was carried out to assess the significance
of the risk differences. The I2 was calculated by χ2 test to
assess the variability due to heterogeneity rather than
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chance. A substantial heterogeneity was assumed with
I2 > 50%. 95% CI for mortality and neurologic outcome
were calculated with the Wilson method and placed in
forest plots, and statistical significance was assumed for
p < 0.05. The presence of publication bias was evaluated
by trim and fill. The trim and fill method estimates the
number of missing studies from a meta-analysis due to
the suppression of the most extreme results on one side
of the funnel plot. Then, this method augments the
observed data and recomputes the summary estimate
based on the complete data. The trim and fill outputs
were obtained with iterations. Analyses were performed
for all the selected studies, as well as grouped by RCT
vs. observational trials. Statistical analysis was conducted
by Review Manager 5.3 software, and funnel and forest
plots were developed.
Results
Study selection
A total of 6886 records were identified after the initial re-
search. After the first screening procedure, 46 studies were
assessed for eligibility (Fig. 1). Of those, 24 were excluded
after a full-paper analysis (Additional file 1: Table S2); a
total of 22 studies [12–19, 23–37], including 8027 pa-
tients, were eventually included for meta-analysis.
Study characteristics
The characteristics of the selected studies are summarized
in Table 1 and Additional file 1. We identified 4 RCTs
(high quality of evidence for two [12, 33] and moderate
for two [13, 24]; Additional file 1: Table S3), four pro-
spective studies (low level of evidence [16, 27, 35, 37] with
an additional one comparing a prospective cohort with
historical controls (very low quality of evidence [36]), and
13 retrospective studies (very low quality of evidence [15,
17, 23, 25, 26, 28–32, 34]), with two of them being a sec-
ondary post hoc analysis of RCTs (low quality of evidence
[14, 19]). The risk of bias (RB) was low in one study [14]
and high for all the others (Tables 2 and 3).
Core vs. surface
Nineteen studies compared core to surface TTM
methods (n = 2174 in the core group; n = 5690 in the
surface group) [12–17, 19, 23–32, 36, 37]; unfavorable
neurological outcome was reported in 12 studies (n =
1928 in the core group; n = 5388 in the surface group)
[12–17, 19, 25, 26, 28, 29, 32]. Core methods showed a
lower probability of unfavorable neurological outcome
than surface methods (OR 0.85 [95% CIs 0.75–0.96]; p =
0.008; Fig. 2); however, this was observed in the analysis
of non-RCTs, although RCTs showed a similar trend.
Core methods showed a similar probability of mortality
than surface methods (OR 0.88 [95% CIs 0.62–1.25]; p =
0.21; Fig. 3). No significant heterogeneity was observed
among studies, both for unfavorable neurological out-
come (I2 = 19%) and mortality (I2 = 0%; Additional file 1:
Figures S1 and S2).
Invasive vs. non-invasive
Nineteen studies compared invasive to non-invasive
TTM methods (n = 1797 in the invasive group; n = 6067
in the non-invasive group) [12–17, 19, 23–32, 36, 37];
unfavorable neurological outcome was reported in 12
studies (n = 1551 in the invasive group; n = 5765 in the
non-invasive group) [12–17, 19, 24, 26, 28, 29, 32]. Inva-
sive methods showed a lower probability of unfavorable
neurological outcome than non-invasive methods (OR
0.70 [95% CIs 0.61–0.81]; p < 0.001; Fig. 4); however,
this was observed in the analysis of non-RCTs, al-
though RCTs showed a similar trend. Invasive
methods showed also a lower probability of mortality
than non-invasive methods (OR 0.84 [95% CIs 0.74–
0.94]; p = 0.002; Additional file 1: Figure S3); however,
this was observed only in the analysis of non-RCTs
(n = 13). No significant heterogeneity was observed
among studies, both for unfavorable neurological out-
come (I2 = 0%) and mortality (I2 = 0%; Additional file 1:
Figures S4 and S5).
Fig. 1 PRISMA flow diagram of the search results for original studies
published in English and selection of eligible studies. NT,
normothermia; HT, hypothermia
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TFD vs. no-TFD
Eight studies compared TFD to non-TFD TTM methods
(n = 2862 in the TFD group; n = 2116 in the non-TFD
group) [12, 25, 26, 28, 29, 32, 33, 37]; unfavorable neuro-
logical outcome was reported in 6 studies (n = 2865 in
the TFD group; n = 2076 in the non-TFD group) [12, 26,
Table 1 Summary of studies comparing different methods for targeted temperature management (TTM) in adult cardiac arrest
patients
Author,
year [ref]
Study OHCA/
IHCA
Patients Target
temperature
Duration
TTM
Mortality Neurological
outcome
TTM method 1 (n),
TFD (Y/N)
TTM method 2 (n),
TFD (Y/N)
LOE
Look, 2018 [13] RCT OHCA 45 32–34 °C 24 h Hospital
discharge
Hospital
discharge
Endovascular
(23), Y
Blankets (22), Y Moderate
Glover, 2016 [14] R* OHCA 934 33 or 36 °C 24 h 6 months 6 months Endovascular
(240), Y
Surface (694), Y Low
Deye, 2015 [12] RCT OHCA 400 32–34 °C 24 h 3 months 28 days Endovascular
(203), Y
Surface (197), N High
Oh, 2015 [15] R OHCA 803 32–34 °C 24 h Hospital
discharge
Hospital
discharge
Endovascular
(244), Y
Surface (559), Y Very low
De Waard, 2015
[23]
R OHCA 173 32–34 °C 24 h Hospital
discharge
NR Endovascular
(97), Y
Blankets (76), Y Very low
Pittl, 2013 [24] RCT Both 80 32–34 °C 24 h Hospital
discharge
Hospital
discharge
Endovascular
(39), Y
Blankets (39), Y Moderate
Tomte, 2011 [17] R OHCA 167 32–34 °C 24 h 6 months 6 months Endovascular
(75), Y
Blankets (92), Y Very low
Flint, 2007 [31] R Both 42 32–34 °C 24 h Hospital
discharge
NR Endovascular
(19), Y
Blankets (23), Y Very low
Sonder, 2018
[16]
P Both 120 32–34 °C 24 h Hospital
discharge
Hospital
discharge
Endovascular
(48), Y
Blankets (72), Y Low
Gillies, 2010 [32] R Both 83 32–34 °C 12 to
24 h
Hospital
discharge
Hospital
discharge
Endovascular
(42), Y
Blankets (41), N Very low
Ferreira, 2009
[28]
R OHCA 49 32–34 °C 24 h Hospital
discharge
Hospital
discharge
Endovascular
(24), Y
Surface (25), N Very low
Flemming, 2006
[30]
R OHCA 80 32–34 °C 24 h Hospital
discharge
NR Endovascular
(31), Y
Blankets (49), Y Very low
Rosman, 2016
[25]
R Both 34 32–34 °C 24 h ICU
discharge
NR Endovascular
(17), Y
Blankets (17), N Very low
Caulfield, 2011
[27]
P Both 41 32–34 °C 24 h Undefined NR Endovascular
(26), Y
Blankets (15), Y Low
De Fazio, 2019
[19]
R* OHCA 352 32–34 °C 24 or
48 h
6 months 6 months Endovascular
(218), Y
Blankets (134), Y Low
Feuchtl, 2007
[29]
R OHCA 39 32–34 °C 24 h Hospital
discharge
NR Endovascular
(19), Y
Cold packs (20), N Very low
Shinada, 2014
[34]
R Both 51 32–34 °C 24 h 1 month 1 month Blanket (40), Y Blankets (11), Y Very low
Rana, 2011 [35] P OHCA 46 32–34 °C 24 h Hospital
discharge
NR Blanket (28), N Cold fluids + packs
(18), N
Low
Heard, 2010 [33] RCT OHCA 64 32–34 °C 24 h Undefined 3months Blanket (34), Y Blankets (30), N High
De Waard, 2013
[36]
P** Both 115 32–34 °C 24 h ICU
discharge
NR Peritoneal lavage
(16), Y
Blankets (99), Y Very low
Kim, 2018 [26] R Both 4246 32–34 °C 24 h Hospital
discharge
Hospital
discharge
Endovascular
(376), Y
Intra-cavitary
(377), N
Blankets (2107), Y
Blankets, pads,
packs (1386), N
Very low
Forkmann, 2015
[37]
P OHCA 63 32–34 °C 24 h 30-day NR Endovascular
(40), Y
Blankets (23), N Low
P prospective, R retrospective, RCT randomized clinical trial, IHCA in-hospital cardiac arrest, OHCA out-of-hospital cardiac arrest, TTM targeted temperature
management, NR not reported, LOE level of evidence, TFD temperature feedback device, Y yes, N no
*Post hoc analysis of RCT
**Versus historical controls
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28, 29, 32, 33]. TFD methods showed a lower probability
of unfavorable neurological outcome than non-TFD
methods (OR 0.64 [95% CIs 0.56–0.74]; p = 0.003; Fig. 5);
however, this was observed in the analysis of non-RCTs,
although RCTs showed a similar trend. Invasive methods
showed also a lower probability of mortality than surface
methods (OR 0.81 [95% CIs 0.72–0.91]; p = 0.01; Add-
itional file 1: Figure S6). No significant heterogeneity
was observed among the studies, both for unfavorable
neurological outcome (I2 = 0%) and mortality (I2 = 0%;
Additional file 1: Figures S7 and S8).
Subgroup analyses
Sixteen studies compared EC to air- or water-circulating
blankets for TTM [13–17, 19, 23–28, 30–32, 37]; ten of them
also reported neurological outcome [13–17, 19, 24, 26, 28,
32]. Endovascular methods showed a lower probability of un-
favorable neurological outcome than air- or water-circulating
blankets (OR 0.76 [95% CIs 0.66–0.87]; p= 0.002; Add-
itional file 1: Figure S9); however, this was observed in the
analysis of non-RCTs, although RCTs showed a similar
trend. Endovascular methods showed also a lower probability
of mortality than air- or water-circulating blankets (OR 0.87
[95% CIs 0.77–0.99]; p= 0.01; Additional file 1: Figure S10);
however, this was observed in the analysis of non-RCTs, al-
though RCTs showed a similar trend. No significant hetero-
geneity was observed among studies, both for unfavorable
neurological outcome (I2 = 0%) and mortality (I2 = 0%; Add-
itional file 1: Figures S11 and S12). Similar results were found
when EC were compared to air- or water-circulating blankets
with TFD (Additional file 1: Figures S13-S16) [13–17, 19, 23,
24, 26, 27, 30, 31]. Four studies compared air- or water-cir-
culating blankets to other surface TTM methods [26,
33–35]; three of them also reported neurological out-
come [26, 33, 34]. Air- or water-circulating blankets
showed a lower probability of unfavorable
Table 2 Summary of the risk of bias (ROB) for non-randomized clinical studies comparing different methods for targeted
temperature management (TTM) in adult cardiac arrest patients. LOW ROB = 0; HIGH ROB = 1
Author, year [ref] Selection of cases Comparability of cohorts Exposure and outcome Overall ROB
Glover, 2016 [14] 1 1 1 High
Oh, 2015 [15] 1 1 0 High
De Waard, 2015 [23] 1 0 0 High
Tomte, 2011 [17] 1 0 1 High
Flint, 2007 [31] 1 0 0 High
Sonder, 2018 [16] 1 0 0 High
Gillies, 2010 [32] 1 0 0 High
Ferreira, 2009 [28] 1 0 0 High
Flemming, 2006 [30] 1 0 0 High
Rosman, 2016 [25] 1 1 0 High
Caulfield, 2011 [27] 1 0 0 High
De Fazio, 2019 [19] 1 0 0 High
Feuchtl, 2007 [29] 1 1 0 High
Shinada, 2014 [34] 1 1 1 High
Rana, 2011 [35] 1 1 0 High
De Waard, 2013 [36] 1 0 0 High
Kim, 2018 [26] 1 0 1 High
Forkmann, 2015 [37] 1 1 1 High
Table 3 Summary of the risk of bias (ROB) for randomized clinical studies comparing different methods for targeted temperature
management (TTM) in adult cardiac arrest patients
Author, year [ref] Sequence generation Allocation concealment Blinding Incomplete data Selective reporting Other bias Overall ROB
Look, 2018 [13] Low Low Probably low Probably low Low Probably high High
Deye, 2015 [12] Low Low Probably low Low Low Low Low
Pittl, 2013 [24] Probably low Probably low Probably low Probably low High High High
Heard, 2010 [33] Low Low Probably low Probably low Low Probably high High
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neurological outcome and mortality than other sur-
face TTM methods (Additional file 1: Figures S17 and
S18). No significant heterogeneity was observed
among studies, both for unfavorable neurological out-
come (I2 = 0%) and mortality (I2 = 0%; Additional file 1:
Figure S19 and S20).
Discussion
This is the first meta-analysis that evaluated the po-
tential effects of the cooling methods on the out-
come in patients undergoing TTM after cardiac
arrest. Our results can be summarized as follows:
core cooling devices are associated with a lower
Fig. 2 Forest plot of poor neurological outcome in randomized clinical trials (RCTs) or non-RCTs: core vs. surface methods. The size of the squares
for the risk ratio reflects the weight of trial in a pooled analysis. Horizontal bars represent 95% confidence intervals
Fig. 3 Forest plot of poor neurological outcome in randomized clinical trials (RCTs) or non-RCTs: core vs. surface methods. The size of the squares
for the risk ratio reflects the weight of trial in a pooled analysis. Horizontal bars represent 95% confidence intervals
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probability of unfavorable neurological outcome, but
not of survival, when compared to surface cooling
devices; similarly, invasive cooling devices and TFD
methods were associated with a higher occurrence of
favorable outcome and survival when compared to
other methods. In particular, endovascular catheter
devices were associated with better outcomes when
compared to air- or water-circulating blankets, even
when blankets were TFD, and blankets had a better
outcome than other surface cooling methods. How-
ever, most of the available data came from non-
RCTs, potentially leading to high risk of bias.
Method of cooling: which is the best TTM device?
The initial studies dealing with the use of TTM after
cardiac arrest used external surface cooling devices,
either with TFD or without temperature control. Since
then, several TTM methods to induce, maintain, or
rewarm patients have been developed; these methods
have been schematically divided into “core” or “surface”
methods [11], although other classifications have been
proposed, i.e., “advanced” methods (using a retro-control
according to the patient’s core temperature) vs. “basic”
methods (such as cold fluids, ice packs without
temperature feedback) [12, 17, 38]. Core and TFD
Fig. 4 Forest plot of poor neurological outcome in randomized clinical trials (RCTs) or non-RCTs: invasive vs. non-invasive methods. The size of
the squares for the risk ratio reflects the weight of trial in a pooled analysis. Horizontal bars represent 95% confidence intervals
Fig. 5 Forest plot of poor neurological outcome in randomized clinical trials (RCTs) or non-RCTs: temperature feedback devices (TFD) vs. non-TFD.
The size of the squares for the risk ratio reflects the weight of trial in a pooled analysis. Horizontal bars represent 95% confidence intervals
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methods enable a more accurate control of patients’
temperature during the cooling phase when compared
with surface techniques [12, 17, 19]; nevertheless,
current guidelines stated that no recommendation could
be given on the optimal method, as there were no data
indicating any potential benefits on survival or neuro-
logical outcome from one specific TTM device [2]. The
use of TFD to better optimize TTM was also recently
suggested by a panel of French experts [39], in both
adult and pediatric CA, despite the lack of studies clearly
demonstrating an effect on the patients’ outcome. More-
over, more recent invasive TTM devices, such as cold
liquid ventilation and esophageal or peritoneal devices,
were not included in this consensus.
A major strength of our study is that we demonstrated
that core, invasive, and/or TFD methods to provide
TTM to CA survivors were associated with an increased
probability of favorable neurological outcome. These
findings were consistent even in the subgroup analyses,
when EC were compared to blanket systems or air- or
water-circulating blankets to other surface methods.
Moreover, the analyses showed a very low heterogeneity.
Unfortunately, findings from RCTs were less convincing.
In the largest multicenter RCT available to date, which
compared EC to basic external methods (i.e., non-inva-
sive, without TFD, n = 400), favorable neurological out-
come at day 28 was not significantly different between
the groups [12], although a strong trend towards a
higher occurrence of intact neurological recovery at day
90 was observed in the EC group (odds ratio 1.51; 95%
CIs 0.96–2.35; p = 0.07). In another study (n = 64), TTM
using a TFD implementing water-circulating blankets
showed a similar proportion of patients with favorable
neurological outcome than cooling blankets and ice
without TFD (46% vs. 38%); however, considering the
total number of patients included, the study was prob-
ably underpowered to demonstrate any difference on the
patients’ outcome [33]. Two other small RCTs, including
a total of 125 patients, also showed a non-significant
trend for a better outcome in patients treated with EC
when compared to TFD blankets [13, 24].
How to explain these results? The limited data pro-
vided by the selected studies restricted our ability to
explore the underlying mechanisms of our findings.
Time to target temperature was significantly shorter in
core and invasive TTM methods than others [12, 33],
although this was not observed in all studies [14, 19].
Moreover, the early initiation of TTM in patients suffer-
ing from OHCA, either intra-arrest or immediately after
ROSC in the pre-hospital setting, did not show any
beneficial effects on survival or neurological outcome
when compared to TTM initiated few hours following
CA, after hospital admission [8, 40]. Analysis of the
rewarming time showed controversial results, with some
studies suggesting a shorter time for EC when compared
to non-TFD blankets and other showing similar findings
for EC and TFD surface methods [19, 25]. Also, the oc-
currence of post-TTM fever was similar between EC and
surface methods [17, 19]. As such, the main difference
between the core and invasive methods, in particular
EC, was associated with a more strict maintenance of
the target temperature during the cooling phase, fewer
periods of over-cooling or unexpected rewarming and
less temperature variability [14, 19, 25]. Importantly,
temperature variability after CA has not been associated
with poor neurological outcome in two retrospective
studies [41, 42]. Considering also the higher risk of side
effects (i.e., infections, thrombosis, hemorrhage) associ-
ated with the use of core and invasive TTM systems, in
particular EC [12, 24, 43], further studies evaluating the
mechanisms involved in potential neuroprotection for
such methods are necessary.
Major weaknesses
The results of this meta-analysis should be considered as
a step forward a future trial evaluating the effects of
cooling methods on the patients’ outcome, in order to
better answer the question on the optimal method to
provide TTM after CA. However, it remains unclear
which methods should be compared in this study. Deye
et al. [12] compared EC (i.e., core, invasive, TFD) with
cooling blankets and ice packs (i.e., surface, non-inva-
sive, and without TFD) and showed a non-significant
but clinically relevant difference between the two groups.
These findings are reinforced by this systematic review
that observed a non-significant but large difference in
the outcome when the two available RCTs comparing
devices with TFD vs. those without TFD were consid-
ered. Whether it would be ethical to expose CA patients
to TTM methods that are less effective in inducing
hypothermia and maintaining a target temperature in
such a trial, this should be further considered. The
most adequate trial should compare EC with water-
circulating blankets using TFD, as in the study from
Pittl et al. [24]. Nevertheless, to reproduce the same
differences in the neurological outcome (i.e., 53% vs.
61%), more than 1200 patients would be necessary. In
the meantime, considering the cost and invasiveness
of some of these devices, the selection of the best
TTM strategy remains challenging; if one could argue
that core and invasive TFD methods should be imple-
mented in those patients with the best prognosis (i.e.,
young patient with a shockable initial rhythm), an-
other could also suggest these methods on patients
with the most severe reperfusion injuries (i.e., pro-
longed resuscitation with poor clinical presentation)
in order to have more chance to prevent them. Also,
it could also be considered unethical to use other
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methods than those with TFD as this would expose pa-
tients to a “poor-quality TTM.” Other relevant aspects on
the selection of TTM methods, such the reduced work-
load of the nursing team and the feasibility of skin counter
warming in case of shivering for EC systems when com-
pared to others, should also be assessed in future studies.
Another major issue of this study is the inclusion of
different methods (i.e., EC, peritoneal lavage, dialysis
techniques) in the same group (i.e., “core”). Also, in
some studies, specific TTM methods were combined, in
a variable proportion of patients, with cold fluids or iced
packs; the role of such additional interventions on the
measured outcome remains unknown. However, this
allowed the selection of all available studies in the litera-
ture comparing at least two different methods of TTM,
with a more complete assessment of the study hypoth-
esis. Also, some additional data, such as side effects or
speed and precision of cooling, were not collected. How-
ever, the time from arrest to target temperature was not
further analyzed as this information would be largely
biased by the retrospective data collection of most of the
studies included in this report. Similarly, the issue of the
adverse events has already been discussed in another
study [5]. Also, the performance for each TTM method
was not routinely reported in all studies. Finally, we
could not calculate the minimal number of patients to
be included in the meta-analysis, and most of the studies
had a high risk of bias, which would reduce the robust-
ness of our findings.
Conclusions
In this meta-analysis, specific TTM methods (i.e., core,
invasive, and with TFD) were associated with a lower
probability of poor neurological outcome when com-
pared to other methods in adult CA survivors. However,
most of the existing literature is based on retrospective
or prospective studies, with a high risk of bias, suggest-
ing new directions for future trials.
Additional file
Additional file 1: Table S1. Extracted data in each study assessed for
eligibility. Table S2. Full text articles excluded, not fitting eligibility
criteria. Figure S1. and S2. Funnel plot for studies comparing the impact
of core and surface methods on poor neurological outcome (left) and
mortality (right). The outer dashed lines indicate the triangular region
within which 95% of studies are expected to lie in the absence of biases
and heterogeneity. The solid vertical line corresponds to no intervention
effect. Figure S3. Forest plot of mortality in randomized clinical trials
(RCTs) or non-RCTs: invasive vs. non-invasive TTM methods. Size of
squares for risk ratio reflects weight of trial in pooled analysis. Horizontal
bars represent 95% confidence intervals. Figure S4. and S5. Funnel plot
for studies comparing the impact of invasive and non-invasive TTM
methods on poor neurological outcome (left) and mortality (right). The
outer dashed lines indicate the triangular region within which 95% of
studies are expected to lie in the absence of biases and heterogeneity.
The solid vertical line corresponds to no intervention effect. Figure S6.
Forest plot of mortality in randomized clinical trials (RCTs) or non-RCTs:
temperature feedback device (TFD) vs. non-TFD TTM methods. Size of
squares for risk ratio reflects weight of trial in pooled analysis. Horizontal
bars represent 95% confidence intervals. Figure S7. and S8. Funnel plot
for studies comparing the impact of temperature feedback device (TFD)
and non-TFD TTM methods on poor neurological outcome (left) and
mortality (right). The outer dashed lines indicate the triangular region
within which 95% of studies are expected to lie in the absence of biases
and heterogeneity. The solid vertical line corresponds to no intervention
effect. Figure S9. Forest plot of poor neurological outcome in
randomized clinical trials (RCTs) or non-RCTs: endovascular devices vs. air-
or water-circulating blankets. Size of squares for risk ratio reflects weight
of trial in pooled analysis. Horizontal bars represent 95% confidence
intervals. Figure S10. Forest plot of mortality in randomized clinical trials
(RCTs) or non-RCTs: endovascular devices vs. air- or water-circulating
blankets. Size of squares for risk ratio reflects weight of trial in pooled
analysis. Horizontal bars represent 95% confidence intervals. Figure S11.
and S12. Funnel plot for studies comparing the impact of endovascular
devices vs. air- or water-circulating blankets on poor neurological
outcome (left) and mortality (right). The outer dashed lines indicate the
triangular region within which 95% of studies are expected to lie in the
absence of biases and heterogeneity. The solid vertical line corresponds
to no intervention effect. Figure S13. Forest plot of poor neurological
outcome in randomized clinical trials (RCTs) or non-RCTs: endovascular
devices vs. air- or water-circulating blankets with temperature feedback
device (TFD). Size of squares for risk ratio reflects weight of trial in pooled
analysis. Horizontal bars represent 95% confidence intervals. Figure S14.
Forest plot of mortality in randomized clinical trials (RCTs) or non-RCTs:
endovascular devices vs. air- or water-circulating blankets with
temperature feedback device (TFD). Size of squares for risk ratio reflects
weight of trial in pooled analysis. Horizontal bars represent 95%
confidence intervals. Figure S15. and S16. Funnel plot for studies
comparing the impact of endovascular devices vs. air- or water-
circulating blankets with temperature feedback device (TFD) on poor
neurological outcome (left) and mortality (right). The outer dashed lines
indicate the triangular region within which 95% of studies are expected
to lie in the absence of biases and heterogeneity. The solid vertical line
corresponds to no intervention effect. Figure S17. Forest plot of poor
neurological outcome in randomized clinical trials (RCTs) or non-RCTs:
blankets vs. other surface TTM methods. Size of squares for risk ratio
reflects weight of trial in pooled analysis. Horizontal bars represent 95%
confidence intervals. Figure S18. Forest plot of mortality in randomized
clinical trials (RCTs) or non-RCTs: blankets vs. other surface TTM methods.
Size of squares for risk ratio reflects weight of trial in pooled analysis.
Horizontal bars represent 95% confidence intervals. Figure S19. and S20.
Funnel plot for studies comparing the impact of blankets vs. other
surface TTM methods on poor neurological outcome (left) and mortality
(right). The outer dashed lines indicate the triangular region within which
95% of studies are expected to lie in the absence of biases and
heterogeneity. The solid vertical line corresponds to no intervention
effect. (DOCX 6046 kb)
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